115 related articles for article (PubMed ID: 12842047)
1. Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm.
Kang BS; Cooper DR; Devedjiev Y; Derewenda U; Derewenda ZS
Structure; 2003 Jul; 11(7):845-53. PubMed ID: 12842047
[TBL] [Abstract][Full Text] [Related]
2. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
Grootjans JJ; Reekmans G; Ceulemans H; David G
J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
[TBL] [Abstract][Full Text] [Related]
3. PDZ tandem of human syntenin: crystal structure and functional properties.
Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
[TBL] [Abstract][Full Text] [Related]
4. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
[TBL] [Abstract][Full Text] [Related]
5. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
Grootjans JJ; Zimmermann P; Reekmans G; Smets A; Degeest G; Dürr J; David G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13683-8. PubMed ID: 9391086
[TBL] [Abstract][Full Text] [Related]
6. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
[TBL] [Abstract][Full Text] [Related]
7. The binding of the PDZ tandem of syntenin to target proteins.
Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
[TBL] [Abstract][Full Text] [Related]
8. The PDZ2 domain of syntenin at ultra-high resolution: bridging the gap between macromolecular and small molecule crystallography.
Kang BS; Devedjiev Y; Derewenda U; Derewenda ZS
J Mol Biol; 2004 Apr; 338(3):483-93. PubMed ID: 15081807
[TBL] [Abstract][Full Text] [Related]
9. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif.
Lin D; Gish GD; Songyang Z; Pawson T
J Biol Chem; 1999 Feb; 274(6):3726-33. PubMed ID: 9920925
[TBL] [Abstract][Full Text] [Related]
10. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane.
Zimmermann P; Meerschaert K; Reekmans G; Leenaerts I; Small JV; Vandekerckhove J; David G; Gettemans J
Mol Cell; 2002 Jun; 9(6):1215-25. PubMed ID: 12086619
[TBL] [Abstract][Full Text] [Related]
11. Rat protein tyrosine phosphatase eta physically interacts with the PDZ domains of syntenin.
Iuliano R; Trapasso F; Samà I; Le Pera I; Martelli ML; Lembo F; Santoro M; Viglietto G; Chiariotti L; Fusco A
FEBS Lett; 2001 Jun; 500(1-2):41-4. PubMed ID: 11434923
[TBL] [Abstract][Full Text] [Related]
12. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K
FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616
[TBL] [Abstract][Full Text] [Related]
14. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.
Fernández-Larrea J; Merlos-Suárez A; Ureña JM; Baselga J; Arribas J
Mol Cell; 1999 Apr; 3(4):423-33. PubMed ID: 10230395
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
16. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions.
Mortier E; Wuytens G; Leenaerts I; Hannes F; Heung MY; Degeest G; David G; Zimmermann P
EMBO J; 2005 Jul; 24(14):2556-65. PubMed ID: 15961997
[TBL] [Abstract][Full Text] [Related]
17. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells.
Cohen AR; Woods DF; Marfatia SM; Walther Z; Chishti AH; Anderson JM
J Cell Biol; 1998 Jul; 142(1):129-38. PubMed ID: 9660868
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.
Geijsen N; Uings IJ; Pals C; Armstrong J; McKinnon M; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Science; 2001 Aug; 293(5532):1136-8. PubMed ID: 11498591
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
Sugi T; Oyama T; Morikawa K; Jingami H
Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
[TBL] [Abstract][Full Text] [Related]
20. Single-amino acid substitutions alter the specificity and affinity of PDZ domains for their ligands.
Gee SH; Quenneville S; Lombardo CR; Chabot J
Biochemistry; 2000 Nov; 39(47):14638-46. PubMed ID: 11087420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]